Jayne Louise Wilson

Jayne Louise Wilson

Auto-generated profile, based on publicly available information

Jayne Louise Wilson

Center for Pathobiochemistry and Genetics, Institute of Medical Genetics, Medical University of Vienna, Vienna, Austria

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Cell Reports
Verified
Journal Article
Open access
JWJayne Louise Wilson
Jayne Louise Wilson
Thomas NägeleThomas Nägele
Thomas Nägele
MLMonika Linke
Monika Linke
FDFlorian Demel
Florian Demel
SFStephanie D. Fritsch
Stephanie D. Fritsch
WWWolfram Weckwerth
Wolfram Weckwerth
Mechanistic or mammalian target of rapamycin complex 1 (mTORC1) is an important regulator of effector functions, proliferation, and cellular metabolism in macrophages. The biochemical processes that are controlled by mTORC1 are still being defined. Here, we demonstrate that integrative multiomics in conjunction with a data-driven inverse modeling approach, termed COVRECON, identifies a biochemical node that influences overall metabolic profiles and reactions of mTORC1-dependent macrophage metabolism. Using a combined approach of metabolomics, proteomics, mRNA expression analysis, and enzymatic activity measurements, we demonstrate that Tsc2, a negative regulator of mTORC1 signaling, critically influences the cellular activity of macrophages by regulating the enzyme phosphoglycerate dehydrogenase (Phgdh) in an mTORC1-dependent manner. More generally, while lipopolysaccharide (LPS)-stimulated macrophages repress Phgdh activity, IL-4-stimulated macrophages increase the activity of the enzyme required for the expression of key anti-inflammatory molecules and macrophage proliferation. Thus, we identify Phgdh as a metabolic checkpoint of M2 macrophages.

27 February 2024 in Cellular & Molecular Immunology
Verified
Journal Article
Open access
PDF file
ZCZhengnan Cai
Zhengnan Cai
WLWan Li
Wan Li
SHSonja Hager
Sonja Hager
JWJayne Louise Wilson
Jayne Louise Wilson
LALeila Afjehi-Sadat
Leila Afjehi-Sadat
WWWolfram Weckwerth
Wolfram Weckwerth
Phosphoglycerate dehydrogenase (PHGDH) has emerged as a crucial factor in macromolecule synthesis, neutralizing oxidative stress, and regulating methylation reactions in cancer cells, lymphocytes, and endothelial cells. However, the role of PHGDH in tumor-associated macrophages (TAMs) is poorly understood. Here, we found that the T helper 2 (Th2) cytokine interleukin-4 and tumor-conditioned media upregulate the expression of PHGDH in macrophages and promote immunosuppressive M2 macrophage activation and proliferation. Loss of PHGDH disrupts cellular metabolism and mitochondrial respiration, which are essential for immunosuppressive macrophages. Mechanistically, PHGDH-mediated serine biosynthesis promotes α-ketoglutarate production, which activates mTORC1 signaling and contributes to the maintenance of an M2-like macrophage phenotype in the tumor microenvironment. Genetic ablation of PHGDH in macrophages from tumor-bearing mice results in attenuated tumor growth, reduced TAM infiltration, a phenotypic shift of M2-like TAMs toward an M1-like phenotype, downregulated PD-L1 expression and enhanced antitumor T-cell immunity. Our study provides a strong basis for further exploration of PHGDH as a potential target to counteract TAM-mediated immunosuppression and hinder tumor progression.

1 February 2016 in Biochemical Pharmacology
Verified
Journal Article
Closed access
SFSarah Fayad-Kobeissi
Sarah Fayad-Kobeissi
JRJohary Ratovonantenaina
Johary Ratovonantenaina
HDHubert Dabiré
Hubert Dabiré
JWJayne Louise Wilson
Jayne Louise Wilson
Anne-Marie RODRIGUEZAnne-Marie RODRIGUEZ
Anne-Marie RODRIGUEZ
Roberta ForestiRoberta Foresti
Roberta Foresti

4 October 2019 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
JWJayne Louise Wilson
Jayne Louise Wilson
HMHannah Katharina Mayr
Hannah Katharina Mayr
TWThomas Weichhart
Thomas Weichhart
Metabolic reprogramming is rapidly gaining appreciation in the etiology of immune cell dysfunction in a variety of diseases. Tuberculosis, schistosomiasis, and sarcoidosis represent an important class of diseases characterized by the formation of granulomas, where macrophages are causatively implicated in disease pathogenesis. Recent studies support the incidence of macrophage metabolic reprogramming in granulomas of both infectious and non-infectious origin. These publications identify the mechanistic target of rapamycin (mTOR), as well as the major regulators of lipid metabolism and cellular energy balance, peroxisome proliferator receptor gamma (PPAR-γ) and adenosine monophosphate-activated protein kinase (AMPK), respectively, as key players in the pathological progression of granulomas. In this review, we present a comprehensive breakdown of emerging research on the link between macrophage cell metabolism and granulomas of different etiology, and how parallels can be drawn between different forms of granulomatous disease. In particular, we discuss the role of PPAR-γ signaling and lipid metabolism, which are currently the best-represented metabolic pathways in this context, and we highlight dysregulated lipid metabolism as a common denominator in granulomatous disease progression. This review therefore aims to highlight metabolic mechanisms of granuloma immune cell fate and open up research questions for the identification of potential therapeutic targets in the future.

1 March 2017 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
JWJayne Louise Wilson
Jayne Louise Wilson
FBFrederic Bouillaud
Frederic Bouillaud
AAAna S. Almeida
Ana S. Almeida
Helena L.A. VieiraHelena L.A. Vieira
Helena L.A. Vieira
MOMohand Ouidir Ouidja
Mohand Ouidir Ouidja
Roberto MotterliniRoberto Motterlini
Roberto Motterlini

15 January 2016 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ANAniket Nikam
Aniket Nikam
AOAnthony Ollivier
Anthony Ollivier
MRMichael Rivard
Michael Rivard
JWJayne Louise Wilson
Jayne Louise Wilson
KMKevin Mebarki
Kevin Mebarki
Roberta ForestiRoberta Foresti
Roberta Foresti